KALANasdaqPharmaceutical PreparationsFiscal year ends December 31
KALA BIO, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026
$0.19+0.00 (+1.42%)
Close on Oct 19, 2026
- Market cap
- $14.28K
- P/E (TTM)
- –
- Dividend yield
- –
Kala Bio statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Kala Bio | Industry median |
|---|---|---|
| Market Cap | $3.72M | $197.05M |
| Enterprise Value | -$3.50M | $106.56M |
| PB Ratio | 0.41 | 2.14 |
| P/TBV Ratio | 0.41 | 2.46 |
Income (trailing twelve months)
| Measure | Kala Bio | Industry median |
|---|---|---|
| Operating Income | -$20.99M | -$21.44M |
| Net Income | -$10.08M | -$22.46M |
| EBITDA | -$20.99M | -$16.91M |
Returns
| Measure | Kala Bio | Industry median |
|---|---|---|
| Return on Equity (ROE) | -345.3% | -53.1% |
| Return on Assets (ROA) | -43.2% | -41.0% |
| Return on Capital Employed (ROCE) | -232.1% | -37.8% |
Balance sheet
| Measure | Kala Bio | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $7.23M | $62.42M |
| Net Cash (Debt) | $7.23M | $15.68M |
| Net Cash Per Share | $0.37 | $0.65 |
| Equity (Book Value) | $9.04M | $48.79M |
| Book Value Per Share | $0.47 | $1.36 |
| Tangible Book Value | $9.04M | $23.06M |
| Working Capital | $9.04M | $75.77M |
Financial position
| Measure | Kala Bio | Industry median |
|---|---|---|
| Current Ratio | 6.88 | 3.30 |
| Quick Ratio | 4.70 | 2.39 |
Cash flow (trailing twelve months)
| Measure | Kala Bio | Industry median |
|---|---|---|
| Operating Cash Flow | -$19.86M | -$12.35M |
Efficiency
| Measure | Kala Bio | Industry median |
|---|---|---|
| Profits Per Employee | -$1.68M | -$732.08K |
| Employee Count | 6 | 73 |
Dividends and yields
| Measure | Kala Bio | Industry median |
|---|---|---|
| Earnings Yield | -270.6% | -21.2% |
Shares
| Measure | Kala Bio | Industry median |
|---|---|---|
| Shares Outstanding | 19,339,800 | 59,128,900 |
| Shares Change (YoY) | 2681.3% | 11.1% |
| Shares Change (QoQ) | 4.03% | 0.54% |
| Shares Held by Institutions | 3.17% | 59.4% |
Scores
| Measure | Kala Bio | Industry median |
|---|---|---|
| Altman Z-Score | -96.43 | 0.10 |
| Piotroski F-Score | 2 | 4 |
Calculated by StockData from Kala Bio's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.